AmplifyBio, a leading preclinical CRO and CDMO played a pivotal role in shaping discussions at Phacilitate’s Advanced Therapy ...
A California federal district court denied Gilead Sciences, Inc. and Kite Pharma, Inc.’s motion to dismiss unpaid overtime claims under the Fair Labor Standards Act by two cell therapy specialists ...
Gilead signed a massive deal with Galapagos. After a restructuring, the pharma is still hunting for the potential it saw at ...
Kite Pharma is flying high with the addition of a new member to its senior leadership team. Brian Heath has joined Gilead Sciences’ cell therapy subsidiary as a senior vice president and head of ...
BRAZIL (CNN) - A woman who was pulled out to sea was saved by an Olympic kite surfer who happened to be in the right place at the right time. Olympian Bruno Lobo, 31, says he was making a practice ...
Mankind Pharma Ltd on Wednesday said it has been imposed a GST related penalty of over Rs 2 crore by tax authority in Kolkata over alleged mismatch in figures for the period of FY18 to FY22.
Hearing her screams, he used his kite to bring her safely to shore. Lobo later shared the incident on Instagram, warning about the dangers of the sea and strong tides. “The day that God used me ...
The order had prohibited farmers belonging to the Pharma City Vyatireka Porata Samithi (PCVPS) from holding a foot march and distributing pamphlets opposing the establishment of Pharma City in ...
India has been traditionally quite strong in the pharma sector, with a low cost of manufacturing (30%–35% lower than in the US and Europe), cost-efficient R&D (about 87% less than in developed markets ...
Gilead’s $11.9 billion purchase of Kite Pharma in 2017 didn’t follow the script, with two big write-downs in the value of the asset since then, but a fresh approval for a CAR-T therapy could ...
In a tragic incident in Haridwar, a 40-year-old man lost his life after becoming entangled in a banned kite string, commonly referred to as 'Chinese manjha'. The victim, Ashok Kumar, was a crane ...
Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. In 2024, Fierce Biotech reported 192 ...